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Background & Aims: Hospitalized patients should be screened for nutritional risk and 25 
adequately managed. Being nutritionally ‘at-risk’ increases in-hospital mortality, length of stay 26 
(LOS) and costs, but the impact on actual costs has seldom been assessed. We aimed to 27 
determine nutritional risk screening and management in a Swiss university hospital. The impact 28 
of being nutritionally ‘at-risk’ on in-hospital mortality, LOS and costs was also assessed. 29 
Methods: Retrospective analysis of administrative data for years 2013 and 2014 from the 30 
department of internal medicine of the Lausanne university hospital (8541 hospitalizations, mean 31 
age 72.8±16.5 years, 50.4% women). Being nutritionally ‘at-risk’ was defined as a Nutritional 32 
risk screening-2002 score≥3 and nutritional managements were collected from medical records. 33 
Results: Screening increased from 16.5% in 2013 to 41.9% in 2014 (p<0.001), while prevalence 34 
of ‘at-risk’ patients remained stable (64.6% in 2013 and 62.7% in 2014, p=0.37). Prevalence of 35 
‘at-risk’ patients was highest in patients with cancer (85.3% in 2013 and 70.2% in 2014) and 36 
lowest in patients with disease of skin (42% in 2013 and 44.8% in 2014). Less than half of 37 
patients ‘at-risk’ received any nutritional management, and this value decreased between 2013 38 
and 2014 (46.9% vs. 40.3%, p<0.05). After multivariate adjustment, ‘at-risk’ patients had a 3.7-39 
fold (95% confidence interval: 1.91; 7.03) higher in-hospital mortality and higher costs (excess 40 
5642.25±1479.80 CHF in 2013 and 5529.52±847.02 CHF in 2014, p<0.001) than ‘not at-risk’ 41 
patients, while no difference was found for LOS. 42 
Conclusion: Despite an improvement in screening, management of nutritionally ‘at-risk’ 43 
patients is not totally covered yet. Being nutritionally ‘at-risk’ affects three in every five patients 44 
and is associated with increased mortality and hospitalization costs. 45 
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Undernutrition is a critical condition among hospitalized patients, both as a cause and 50 
consequence of disease [1]. Notwithstanding over three decades of knowledge development, the 51 
worldwide prevalence of hospital undernutrition is still high (20 to 50%) mainly due to 52 
difficulties in the identification and adequate management of ‘at-risk’ patients [2, 3]. 53 
Undernutrition status tends to deteriorate during hospital stay, worsening patient’s outcome and 54 
increasing health costs [4, 5]. Adequate screening and nutritional therapy have been shown to 55 
decrease the rate of nutrition-related complications, to decrease in-hospital mortality and to 56 
shorten length of stay (LOS) [6]. According to the European Society for Parenteral and Enteral 57 
Nutrition (ESPEN) recommendations, the Nutrition Risk Screening (NRS-2002) should be used 58 
for screening undernutrition in all hospitalized patients [1]. Still, even nowadays, proper 59 
nutritional risk screening is not performed in many European hospitals [7]; only in some 60 
countries like the United Kingdom, the Netherlands and part of Denmark nutritional risk 61 
screening is mandatory [8, 9].  62 
Switzerland is a small European country with one of the best health systems in the world 63 
[10]. Still, screening for nutritionally ‘at-risk’ patients has been unevenly implemented in 64 
hospitals and there is little information regarding prevalence, determinants, management and 65 
impact on health outcomes and cost of undernutrition [11]. Such information is important for the 66 
adequate management of hospital resources, both in Switzerland and similar countries. 67 
In this study we used data from the department of internal medicine of a Swiss university 68 
hospital to assess the implementation of nutritional risk screening. We also assessed the 69 
prevalence, determinants and management of ‘at-risk’ patients, and impact of being nutritionally 70 




Data collection 73 
This is a retrospective study using electronic administrative data of the department of 74 
internal medicine of the Lausanne university hospital (CHUV) from January 1st, 2013 to 75 
December 31st, 2014. The CHUV is one of the five Swiss university hospitals, with a total staff 76 
of 10,000 and a bed capacity of 1642 (www.chuv.ch). In 2013, the department of internal 77 
medicine of the CHUV started implementing a nutritional risk screening procedure with the use 78 
of NRS-2002; this screening focused mainly, but not exclusively, on patients with heart and/or 79 
respiratory failure at admission. 80 
This study included all adult (≥ 18 years old) patients who stayed for a minimum of one 81 
day (≥ 24 hours) in the department of internal medicine of the CHUV.  82 
Nutritional risk screening and data collection procedure  83 
The patient’s nutritional risk status was evaluated by the NRS-2002 [1]. Nutritional 84 
screening implementation was defined by the presence of NRS-2002 score in the electronic 85 
medical record which contain all the data related to nutritional risk status and managements since 86 
January 2013. In brief, according to the CHUV guideline, patients were interviewed by nursing 87 
staff at the first 48h of admission about their nutritional risk status and disease severity according 88 
to the NRS-2002 criteria. NRS-2002 score is calculated by adding ‘nutritional score’ of 0 to 3 to 89 
the ‘disease severity score’ of 0 to 3 plus 1 extra score for patients older than 70 years.  90 
The ‘nutritional score’ is defined by adequacy of dietary intake due to three different 91 
parameters 1) quartile decreased of estimated oral food intake requirements, 2) presence of ≥5% 92 
weight loss within the previous 1 to 3 months and 3) low body mass index (<18.5 kg/m2). The 93 
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‘disease severity score’ was categorized as none, slight, moderate and severe with the score of 0 94 
to 3, respectively. A total NRS-2002 score ≥3 was considered as nutritionally ‘at-risk’. 95 
The nutritional management database of the CHUV included dietary regimen, enteral 96 
nutrition (EN) and parenteral nutrition (PN). At the CHUV, all prescriptions given to patients are 97 
coded using the Anatomical Therapeutic Chemical (ATC) classification system and procedures 98 
are coded according to ICD-9CM. EN was defined as prescribed oral nutrition supplements 99 
(ONS) and/or tube feeding according to the ESPEN guideline [12]. PN was defined as any 100 
prescription containing the ATC code B05BA (PN solution or premixed multichamber bag 101 
containing PN) or as a procedure containing the ICD-9CM code 99.15 (Parenteral infusion of 102 
concentrated nutritional substances).  103 
Other variables 104 
Socio-demographic data included age, sex, marital status and coming from home or other 105 
health care facilities. Clinical variables included main diagnosis and vital status at discharge 106 
(alive or dead). Main diagnoses (the most relevant diagnosis for the hospitalization at discharge 107 
according to the responsible physician) were categorized in groups according to the 10th 108 
International Classification of Diseases and related health problems (ICD-10). Main diagnosis 109 
groups are indicated in Supplementary Table 1. Only main diagnosis were used regardless any 110 
subsidiary diagnosis except for disease of circulatory system (Ischemic heart disease and Heart 111 
Failure) and pulmonary diseases (Pneumonia and Chronic obstructive pulmonary disease).  112 
LOS was calculated according to the official Swiss Diagnosis-related group (DRG) 113 
guidelines, available at 114 
swissdrg.org/assets/pdf/Tarifdokumente/SwissDRG_Falldefinitionen_Version_5_2013_f_def.pdf115 
. According to the “midnight rule”, a patient who is admitted at the hospital before midnight and 116 
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who stays at the hospital at midnight is considered as having spent a night at the hospital. 117 
Briefly, LOS is computed using the following formula:  118 
[date of discharge – date of admission]/24 – hours of administrative leave/24. 119 
The dates of discharge and admission include hours and minutes, and the number of hours of 120 
administrative leave (i.e. periods during which the patient is allowed to leave the hospital; only 121 
periods of ≥8 h are taken into account) is rounded to the lowest value. Calculations are made 122 
using hours as the primary unit and the values were provided to us by the hospital administration. 123 
According to the guidelines, only LOS of at least 24h can be considered as hospital treatment; 124 
thus, our inclusion criteria included a minimum stay of 24h. 125 
Contrary to other studies that used DRG costs [13-15], total cost was defined as the actual 126 
costs. The cost of each patient’s expenditures was extracted from the hospital billing system; this 127 
system considers costs related to anesthesia, surgery (including occupation of surgical wards), 128 
imagiology (X-rays, MRI, echography), clinical chemistry, pathology, ICU-related costs, 129 
medical care, external consultations (i.e. a specialist outside the internal medicine ward who is 130 
asked to examine the patient), administrative tasks, food (no-therapeutical), blood products (i.e. 131 
transfusions), drugs (including enteral and parenteral nutrition), medical material (catheters,…), 132 
transport, etc. Summation of all the costs was done to estimate the actual cost of patient care.  133 
Due to anonymization constraints, only month and year of admission and discharge were 134 
available; hence, it was not possible to calculate readmissions within 30 days after discharge as 135 
two admissions occurring in the same month could not be sorted. 136 
Statistical analysis 137 
Statistical analyses were performed using Stata version 14 for windows (Stata Corp, 138 
College Station, Texas, USA). Descriptive results were expressed as number of participants 139 
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(percentage) or as mean ± standard deviation (SD). Bivariate analyses were performed using chi-140 
square or Fisher’s exact test for qualitative variables and Student’s t-test, analysis of variance or 141 
Kruskal-Wallis test for quantitative variables. Multivariate analysis was performed using logistic 142 
regression including sex, age, year, coming from home and main diagnosis in the model; the 143 
results were expressed as odds ratio (OR) and 95% confidence interval (CI). Statistical 144 
significance was assessed for a two-sided test with p<0.05. 145 
Ethics 146 
The study was approved by the Ethics Commission of Canton Vaud (www.cer-vd.ch, 147 
decision 428-14, of Dec 2, 2014) and by the CHUV board of directors (decision of Dec. 5, 2014). 148 
Only routinely collected data was used. Patients were not asked to provide informed written 149 
consent and no intervention was performed. All information was extracted and anonymized 150 
before being handled for analysis.  151 
RESULTS 152 
Study population 153 
Overall, data from 8541 hospitalizations was analyzed. In 2013, the mean age was 154 
72.7±16.4 years and 50% were women, and in 2014 the mean age was 73.0±16.6 years and 155 
50.7% were women. The main characteristics, prevalence and determinants of nutrition 156 
screening and being nutritionally ‘at-risk’ are summarized in Table 1. 157 
Nutritional risk screening  158 
Between 2013 and 2014, total nutrition risk screening increased from 670/4077 (16.5%) 159 
to 1869/4464 (41.9%) of hospitalizations (p-value<0.001). While in 2013 no consistent 160 
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differences were found regarding patients screened and not screened except for older age, in 161 
2014 screening was significantly higher among women and patients aged ≥80 years. Prevalence 162 
of screening was at least 12.2% in all disease categories in 2013, and this value increased to 163 
31.9% in 2014 (Figure 1). Patients discharged with cancer or disease of the circulatory system 164 
had a higher prevalence of screening, but no difference was found regarding prevalence of 165 
screening according to main diagnosis categories between 2013 and 2014 (Table 1). 166 
Multivariate analysis showed that patients aged ≥ 80 years or coming from home had 167 
higher likelihood to be screened [Odds ratio (95% CI): 1.81 (1.56; 2.10) and 1.30 (1.07; 1.58), 168 
respectively]. Compared to patients with a main diagnosis of cancer, patients with pneumonia, 169 
disease of digestive, genitourinary or blood systems had lower odds of screening [Odds ratio 170 
(95% CI): 0.96 (0.75; 1.24); 0.70 (0.55; 0.88); 0.68 (0.51; 0.91); 0.62 (0.44; 0.88), respectively], 171 
while no difference was found for the other diseases (Figure 1). 172 
Nutritional status on admission and its determinants 173 
The implementation of the screening procedure resulted in a 2.7 fold increase in the 174 
number of patients ‘at-risk’ in year 2014 compared to 2013; conversely, the prevalence of ‘at-175 
risk’ patients remained stable: 433/670 (64.6%) in 2013 and 1172/1869 (62.7%) in 2014 (Table 176 
1). Prevalence of ‘at-risk’ patients was highest in patients with cancer (85.3% in 2013 and 70.2% 177 
in 2014) and lowest in patients with disease of skin (42% in 2013 and 44.8% in 2014). 178 
Multivariate analysis showed that women and patients aged ≥80 years had a higher 179 
likelihood of being nutritionally ‘at-risk’ [Odds ratio (95% CI): 1.23 (1.02; 1.48); 4.67 (3.57; 180 
6.09), respectively] while patients who came from home had lower odds of being nutritionally 181 
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‘at-risk’: 0.52 (0.35; 0.76); compared to patients with cancer, patients discharged with another 182 
diagnosis had a lower odds of being nutritionally ‘at-risk’ (Figure 2). 183 
Nutritional managements among patients at risk 184 
Fewer than half of the patients considered as nutritionally ‘at-risk’ received at least one 185 
type of nutritional management (46.9% in 2013 and 40.3% in 2014, p-value<0.05). Also, 186 
approximately one in six of the patients considered ‘not at-risk’ received at least one type of 187 
nutritional management (13.5% in 2013 and 16.3% in 2014, Table 2). The most frequent 188 
management was EN, followed by dietary regimen alone and PN. There were no significant 189 
differences between year 2013 and 2014 regarding dietary regimen and PN, but prevalence of 190 
EN decreased significantly in 2014 compared to 2013 (Table 2).  191 
Impact on in-hospital mortality, length of stay and costs 192 
The impact of being nutritionally ‘at-risk’ on in-hospital mortality, LOS and costs is 193 
summarized in Table 3. In-hospital mortality was higher in patients who were nutritionally ‘at-194 
risk’ in year 2014 but not in 2013. Multivariate analysis confirmed those findings: in 2014, 195 
patients ‘at-risk’ of undernutrition had a 3.7-fold higher risk of dying than patients ‘not at-risk’. 196 
Patients ‘at-risk’ had a longer LOS than patients ‘not at-risk’ in 2013 and 2014, but this 197 
difference was no longer significant after multivariate adjustment. Similarly, after multivariate 198 
adjustment, the likelihood of being above the 90th percentile of LOS did not differ between ‘at-199 
risk’ and ‘not at-risk’ patients (Table 3).  200 
Patients ‘at-risk’ had higher healthcare costs compared to patients ‘not at-risk’ in both 201 
years, and these findings were further confirmed after excluding patients whose costs were 202 
10 
 
higher than 100,000 CHF: compared to ‘not at-risk’ patients, ‘at-risk’ patients had an excess cost 203 
of 5642.25±1479.8 CHF in 2013 and 5529.52±847.02 CHF in 2014. 204 
DISCUSSION 205 
This study showed that nutrition screening improved between 2013 and 2014 in the 206 
department of internal medicine of the CHUV; however, nutritional management is not totally 207 
covered yet. Patients nutritionally ‘at-risk’ have higher in-hospital mortality and hospitalization 208 
costs than patients ‘not at-risk’, while no differences were found for LOS. 209 
Nutritional risk screening  210 
Nutritional risk screening more than doubled between 2013 and 2014. Still, in 2014, 211 
screening was performed in less than half of admitted patients, in contrast with the generally 212 
accepted standards and guidelines [1]. Nevertheless, the 42% screening rate observed in 2014 is 213 
in line with the NutritionDay study which reported a 43% screening rate in western European 214 
countries (including Switzerland) [4] and with a cross-sectional multicenter study which reported 215 
a 40.3% screening rate in the Netherlands [16]. Further, according to one study conducted in 216 
Scandinavia, nutrition screening rates were as low as 40% in Denmark, 21% Sweden and 16% in 217 
Norway [17]. Possible explanations for this low screening rate are lack of sufficient nutrition-218 
related education, clearly defined responsibilities and time of the medical team [18], and it would 219 
be of interested to replicate this study in the forthcoming years in order to confirm if the 220 
observed increase in screening has been maintained. As being nutritionally ‘at-risk’ is highly 221 
prevalent and commonly under-recognized and/or under-treated, universal screening is 222 
paramount among in-hospital patients at admission.  223 
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Nutritional status on admission and its determinants 224 
Three in every five screened patients were ‘at-risk’ (64.6% in 2013 and 62.7% in 2014), a 225 
finding in agreement with previous studies [2, 3] but higher than other studies conducted in 226 
Switzerland (18.2% and 27.8%) [11, 19], Brazil (48.1%) [20] or Denmark (23%) [21]. Several 227 
explanations might be put forward for the higher prevalence observed in this study; first, the 228 
CHUV guideline regarding nutrition risk screening emphasizes screening of high risk patients 229 
(i.e. patients with heart failure or respiratory failure), leading to a positive selection bias; second, 230 
patients in our study were older (72.8±16.5 years) than those included in the Brazilian study 231 
(51.3±18.0 years) and it has been shown that risk of being nutritionally ‘at-risk’ increases with 232 
age [11, 22-24]. 233 
The prevalence of being nutritionally ‘at-risk’ was highest among patients with cancer or 234 
pulmonary disease, in accordance with another study where cancer patients had an almost three-235 
fold higher undernutrition rate than non-cancer patients [20]. Importantly, prevalence of being 236 
nutritionally ‘at-risk’ was above 10% in all main diagnosis categories, which is in line with the 237 
results reported by one Norwegian [25] and one multicenter [3] studies. Thus, our results 238 
strengthen the recommendation that nutritional risk screening should be performed in all 239 
hospitalized patients, as the prevalence of ‘at-risk’ status is high irrespective of the main 240 
diagnosis considered. Still, in the absence of adequate screening capacities, focusing on patients 241 
with cancer, COPD and endocrine, nutritional and metabolic diseases might be an option. 242 
Nutritional managements 243 
Evidence shows that management of undernourished or nutritionally ‘at-risk’ patients 244 
should be initiated immediately to improve clinical outcomes [6]. In this study, less than half of 245 
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the nutritionally ‘at-risk’ patients received at least one type of nutritional managements during 246 
their hospitalization. Still, this low management rate is in accordance with two observational 247 
multicenter studies conducted in the Netherlands [21] and Denmark [16], where fewer than half 248 
of all ‘at-risk’ patients received nutritional managements. Further, the management rates 249 
observed in our study are higher than in Brazil (10.1% of patients on EN) [20], the Netherlands 250 
(27.9% of patients receiving ONS) [26] or Switzerland (23.2% of patients receiving a nutritional 251 
management) [19]. Overall, our results suggest that, despite being far from optimal, the 252 
nutritional management rates among ‘at-risk’ patients observed in this study are comparable or 253 
even slightly better than reported in the literature; notwithstanding, improvements should be 254 
made so that all ‘at-risk’ patients might benefit from an adequate nutritional management. 255 
Finally, the fact that the proportion of ‘at-risk’ patients benefiting from nutritional managements 256 
decreased from 46.9% in 2013 to 40.3% in 2014 is of concern and should be monitored in future 257 
studies. 258 
Impact on in-hospital mortality, length of stay and costs 259 
 Being nutritionally ‘at-risk’ significantly increased in-hospital mortality, a finding in line 260 
with other studies [3, 19, 21] which shows the importance of adequate management of such 261 
patients in order to reduce fatal events. 262 
On bivariate analysis, ‘at-risk’ patients showed a significant higher LOS than ‘not at-risk’ 263 
patients, a finding also in accordance with previous studies [3, 5, 21]. One study conducted in 264 
Switzerland reported a two-fold increase in LOS among undernourished patients compared to 265 
well-nourished patients (10.2±16.0 vs. 5.1±8.2 days, respectively) [27], and another Swiss study 266 
reported a stepwise increase in LOS from 6 days among patients with NRS-2002<3 to 10 days 267 
among patients with NRS-2002≥3 [19]. Conversely, after multivariate adjustment, no significant 268 
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association was found between nutritional risk status and LOS, although LOS tended to be one 269 
day higher among ‘at-risk’ compared to ‘not at-risk’ patients. Although significant association 270 
between being nutritionally ‘at-risk’ and increased LOS has been reported by several studies [3, 271 
5, 21], most of these studies were not adjusted for possible confounding factors such as age, sex, 272 
social factors such as living alone or lack of social/family support, and main diagnosis category, 273 
which could explain the weaker association in our study.  274 
After excluding extreme expenditures, being nutritionally ‘at-risk’ was associated with 275 
approximately 5500 CHF (€ 5085 as of December 2015) higher actual healthcare costs, which is 276 
consistent with our previous review where being undernourished led to an additional cost 277 
ranging between 1640 € and 5829 € [5]. In addition, another study also showed that early 278 
nutrition therapy for ‘at-risk’ patients is highly cost-effective compared to delayed nutrition 279 
therapy [28].  As LOS did not differ significantly between ‘at-risk’ and ‘not at-risk’ groups, it is 280 
unlikely that these extra costs are solely due to an increase in LOS. Thus, it will be of interest to 281 
further assess the different types of health expenditures (i.e. related to treatments, X-rays, 282 
nutritional support…) among nutritionally ‘at-risk’ patients in Switzerland. 283 
Overall, our results indicate that the increase in nutritional screening which occurred 284 
between 2013 and 2014 at the department of internal medicine of the CHUV was not followed 285 
by a similar improvement in nutritional. Thus, future actions should aim at improving nutritional 286 
management of nutritionally ‘at-risk’ patients, by issuing institutional guidelines and by 287 
implementing a more thorough training and collaboration between doctors, nurses and dieticians. 288 
Automatic notifications to the department of clinical nutrition of the presence of an ‘at-risk’ 289 
patient could also be implemented, so that a better quantification of the resources used/needed to 290 
manage in-hospital malnutrition and their impact on health outcomes and cost can be performed. 291 
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Moreover, future studies should allow a better characterization of the costs specifically 292 
associated with being nutritionally ‘at-risk’. 293 
Strengths and limitations 294 
This study was built on real-life data from the CHUV; namely, all adult hospitalizations 295 
occurring in years 2013 and 2014 were included and costs were evaluated based on actual 296 
expenditures and not on DRG-related codes. 297 
Some limitations should also be acknowledged. First, there is no standard procedure 298 
regarding nutritional screening for all hospitals in Switzerland, so these findings might not be 299 
applicable in other hospitals. Still, our results provided a baseline frame for further comparisons. 300 
Second, the analysis was limited to a single department, and it is possible that nutritional 301 
screening might be performed differently in other departments. Still, some studies also rely on 302 
data from single departments [26, 29, 30]. Finally, due to the selection process in the hospital 303 
guideline, a possible selection bias might occur, i.e. diagnoses with a high prevalence of ‘at-risk’ 304 
patients (such as heart failure and COPD) being selected. Although this procedure might increase 305 
the prevalence of patients ‘at-risk’, it would not influence neither their management nor the 306 
effect of being ‘at-risk’ on outcomes. 307 
Conclusion 308 
Between 2013 and 2014, the increase in nutritional risk screening at the department of 309 
internal medicine was not followed by a similar increase in nutritional management of ‘at-risk’ 310 
patients. Being nutritionally ‘at-risk’ affects three in every five patients and is associated with 311 
increased mortality and hospitalization costs. Implementation of adequate nutritional care and 312 
evaluation of its impact on health outcomes and expenditures are needed. 313 
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Table 1. Number and main characteristics of all hospitalizations (eligible), hospitalizations where nutritional risk screening was 405 
performed (screened) and hospitalizations with a positive (‘at-risk’) nutritional screening, department of internal medicine of the 406 
CHUV, 2013 and 2014. 407 
 Eligible  Screened (yes)  At-risk (yes)  
 2013 2014 p-value 2013 2014 p-value 2013 2014 p-value 
N 4077  4464  670 1869 <0.001 433 1172 0.37 
Women 2037 (49.9) 2264 (50.7) 0.48 328 (49.0) 1019 (54.5) <0.05 232 (53.6) 672 (57.3) 0.17 
Age categories           
18-59 809 (19.8) 879 (19.7) 0.23 107 (16.0) 269 (14.4) <0.05 42 (9.7) 117 (9.1) 0.02 
60-79 1544 (37.8) 1620 (36.3)  255 (38.0) 628 (33.6)  162 (37.4) 353 (30.1) 
80+ 1724 (42.3) 1965 (44.0)  308 (46.0) 972 (52.0)  229 (52.9) 702 (59.9) 
Living in a couple § 1638 (41.4) 1830 (42.2) 0.48 257 (39.7) 717 (39.2) 0.82 162 (38.5) 422 (36.9) 0.56 
Coming from home 3794 (93.1) 4103 (91.9) <0.05 622 (92.8) 1750 (93.6) 0.47 393 (90.8) 1088 (92.8) 0.16 
Main diagnosis          
Cancer 409 (10.0) 505 (11.3) <0.05 61 (9.1) 225 (12.1) 0.70 52 (12.0) 158 (13.5) 0.85 
Infection 330 (8.1) 346 (7.7)  47 (7.0) 137 (7.3)  32 (7.4) 85 (7.3) 
Pulmonary disease 224 (5.5) 266 (6.0)  38 (5.7) 113 (6.1)  26 (6.0) 76 (6.5)  
Pneumonia 397 (9.7) 352 (7.9)  58 (8.6) 129 (6.9)  38 (8.8) 85 (7.3) 
COPD  149 (3.6) 159 (3.5)  19 (2.9) 62 (3.3)  13 (3.0) 40 (3.4) 
Digestive system 361 (8.8) 397 (8.9)  56 (8.4) 130 (7.0)  39 (9.0) 81 (6.9) 
Endocrine, nutritional and metabolic 140 (3.4) 141 (3.2)  21 (3.1) 52 (2.8)  13 (3.0) 36 (3.1) 
Circulatory system 346 (8.5) 367 (8.2)  57 (8.5) 152 (8.1)  26 (6.0) 90 (7.7) 
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Ischemic heart disease 126 (3.1) 123 (2.7)  23 (3.4) 57 (3.1)  13 (3.0) 30 (2.5) 
Heart Failure 341 (8.4) 334 (7.5)  57 (8.5) 153 (8.2)  39 (9.0) 91 (7.7) 
Symptoms, abnormal findings + injury 448 (11.0) 572 (12.8)  90 (13.4) 283 (15.2)  58 (13.4) 171 (14.6) 
Genitourinary system 162 (4.0) 199 (4.5)  23 (3.4) 68 (3.65)  17 (3.9) 36 (3.1) 
Blood 115 (2.8) 138 (3.1)  14 (2.1) 44 (2.35)  8 (1.8) 27 (2.3) 
Nervous system 94 (2.3) 83 (1.8)  20 (3.0) 39 (2.1)  11 (2.5) 24 (2.0) 
Skin 55 (1.3) 64 (1.4)  12 (1.8) 29 (1.6)  5 (1.2) 13 (1.1) 
Musculoskeletal system 119 (2.9) 154 (3.5)  20 (3.0) 66 (3.5)  9 (3.0) 44 (3.8) 
Rehabilitation 261 (6.4) 264 (5.9)  54 (8.1) 130 (7.0)  34 (7.8) 85 (7.2)  
COPD, Chronic obstructive pulmonary disease. § 3% of observations had missing data. Results are presented as number of 408 
hospitalizations and (column percentage). Between-year comparisons performed by chi-square. 409 
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Table 2. Nutrition management of nutritionally ‘not at-risk’ and ‘at-risk’ adult patients in the 410 
department of internal medicine of the CHUV, 2013 and 2014. 411 
 2013 2014 p-value 
 Not at risk At-risk Not at risk At-risk At-risk 
N (row %) 237 (35.4) 433 (64.6) 697 (37.3) 1172 (62.7) 0.37 
Dietary regimen 10 (4.2) 37 (8.6) 19 (2.7) 103 (8.8) 0.87 
Enteral nutrition 29 (12.2) 196 (45.3) 106 (15.2) 458 (39.1) <0.05 
Parenteral nutrition 1 (0.4) 4 (0.9) 0 (0) 9 (0.8) 0.75 † 
Overall  32 (13.5) 203 (46.9) 114 (16.3) 473 (40.3) <0.05 
‘At-risk’ status defined by a NRS-2002 ≥ 3. Results are presented as number of patients and 412 
(column percentage). Between-year comparisons by chi-square or Fisher’s exact test (†). Overall 413 
number of patients is lower than the sum of all managements due to the fact that several patients 414 
received multiple managements (i.e. dietary regimen + enteral nutrition). 415 
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Table 3. Impact of being nutritionally ‘at-risk’ on in-hospital mortality, length of stay and costs for patients admitted in the 416 
department of internal medicine of the CHUV, 2013 and 2014. 417 
 
2013  2014  
Not at risk At-risk P-value Not at risk At-risk P-value 
N 228 402  685 1084  
In-hospital mortality       
Bivariate 9 (3.8) 31 (7.2) 0.08 12 (1.7) 88 (7.5) 0.001 
Multivariate, OR (95% CI) § 1 (ref.) 1.57 (0.65 - 3.79) 0.30 1 (ref.) 3.67 (1.91 - 7.03) 0.001 
Length of stay (days)       
Bivariate, mean ± SD 12.9 ± 9.8 16.0 ± 13.6 0.01 13.3 ± 10.2 16.7 ± 14.3 0.001 
Multivariate, mean ± SE § 14.1 ± 0.9 15.2 ± 0.6 0.319 14.8 ± 0.5 15.6 ± 0.4 0.155 
LOS>90th percentile       
Bivariate 23 (9.7) 56 (12.9) 0.215 68 (9.75) 186 (15.9) 0.001 
Multivariate, OR (95% CI) § 1 (ref.) 0.86 (0.46 - 1.61) 0.64 1 (ref.) 1.13 (0.80 - 1.60) 0.50 
Actual costs (CHF)       
Bivariate, mean ± SD 20,707.7 ± 17,433.4 31,300.5 ± 39,597.8 0.001† 23,535.0 ± 24,754.9 33,649.1 ± 51,594.7 0.001† 
Multivariate, mean ± SE § 19,672.7 ± 2313.0 31,566.3 ± 1656.3 0.001 21,670.3 ± 1681.2 34,419.3 ± 1282.85 0.001 
Actual costs (CHF) (< 100,000)       
Bivariate, mean ± SD 20,006.1 ± 13,785.5 25,726.2 ± 18,206.2 0.001† 20,541.2 ± 14,355.0 25,868.7 ± 18,683.5 0.001† 
Multivariate, mean ± SE § 19,888.8 ± 1154.7 25,531 ± 839.4 0.001 20,291.8 ± 656.2 25,821.3 ± 505.8 0.001 
NRS-2002, nutrition risk screening 2002; CI, confidence interval; SD, standard deviation; SE, standard error. ‘At-risk’ status defined 418 
by a NRS-2002 ≥ 3. § adjusting for year, sex, marital status and main disease categories. Statistical analysis by chi-square and logistic 419 
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regression for in-hospital mortality and LOS>90th percentile, and by Kruskall-Wallis (†) or analysis of variance for length of stay and 420 
actual costs. 421 
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Figure legends 422 
Figure 1. Prevalence of nutrition screening among adult patients hospitalized in the department of internal medicine of the CHUV for 423 
years 2013 and 2014. Results are shown according to the main disease at discharge and expressed as percentage and as multivariate-424 
adjusted (sex, age, year and coming from home or elsewhere) Odds ratio (OR) and 95% confidence interval (CI). P, p-value testing the 425 
OR against unity. 426 
Figure 2. Prevalence of being nutritionally ‘at-risk’ among adult patients hospitalized in the department of internal medicine of the 427 
CHUV for years 2013 and 2014. Results are shown according to the main disease at discharge and expressed as percentage of 428 
screened patients and as multivariate-adjusted (sex, age, year and coming from home or elsewhere) Odds ratio (OR) and 95% 429 
confidence interval (CI). P, p-value testing the OR against unity.  430 
26 
 








Supplementary Table 1: 10th International Classification of Diseases and related health 
problems (ICD-10) codes used. 
Main diagnosis  ICD-10 codes 
Cancer  C00-D09 
Infection  A00-B00 
Pulmonary disease  J00-J99 
Pneumonia  J12-18 
Chronic obstructive pulmonary  J40-J47 
Disease of digestive system  K00-K93 
Endocrine, Nutritional and metabolic diseases  E00-E90 
Disease of the circulatory system  I00-I99 
Ischemic heart disease  I20-I25 
Heart Failure  I50 
Symptom and abnormal findings + injury  R00-R99; S00-S99 
Disease of genitourinary system  N00-N99 
Disease of blood  D50-D89 
Disease of nervous system  G00-G99 
Disease of skin  L00-L99 
Disease of the musculoskeletal  M00-M99 
Rehabilitation  Z50.80-Z50.89 
 
